{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:08:50Z","timestamp":1793279330301,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00417-026-07260-x","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T04:27:05Z","timestamp":1777264025000},"page":"2733-2738","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Validation of the FIRST-ROP algorithm in a tertiary care center in Greece"],"prefix":"10.1007","volume":"264","author":[{"given":"Celine","family":"Chaaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Moutzouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Altamirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srujay","family":"Pandiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Hoyek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Raad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Brant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetrios G.","family":"Vavvas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asimina","family":"Mataftsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimesh A.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"1","key":"7260_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/pr.2013.205","volume":"74","author":"H Blencowe","year":"2013","unstructured":"Blencowe H, Lawn JE, Vazquez T, Fielder A, Gilbert C (2013) Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res 74(1):35\u201349. https:\/\/doi.org\/10.1038\/pr.2013.205","journal-title":"Pediatr Res"},{"key":"7260_CR2","unstructured":"Martin JA, Osterman MJK (2018) Describing the increase in preterm births in the United States, 2014\u20132016. NCHS Data Brief (312):1\u20138 https:\/\/pubmed.ncbi.nlm.nih.gov\/30044213\/"},{"key":"7260_CR3","doi-asserted-by":"publisher","unstructured":"Altamirano F, Yuan M, Hoyek S, Hu D, Abidi M, Chaaya C et al (2025) Evaluating the utility of initial examinations in retinopathy of prematurity. Ophthalmology S0161642025000053. https:\/\/doi.org\/10.1016\/j.ophtha.2025.01.004","DOI":"10.1016\/j.ophtha.2025.01.004"},{"key":"7260_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ajo.2023.03.007","volume":"252","author":"NA Patel","year":"2023","unstructured":"Patel NA, Hoyek S, Al-Khersan H, Fan KC, Yannuzzi NA, Davila J et al (2023) Retinopathy of Prematurity Outcomes of Neonates Meeting Only a Single Screening Criterion: Proposal of the TWO-ROP Algorithm. Am J Ophthalmol 252:147\u2013152. https:\/\/doi.org\/10.1016\/j.ajo.2023.03.007","journal-title":"Am J Ophthalmol"},{"key":"7260_CR5","first-page":"233","volume":"102","author":"WV Good","year":"2004","unstructured":"Good WV, Early Treatment for Retinopathy of Prematurity Cooperative Group (2004) Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc 102:233\u2013248 discussion 248\u2013250","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"2","key":"7260_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.earlhumdev.2007.12.004","volume":"84","author":"AR Wilkinson","year":"2008","unstructured":"Wilkinson AR, Haines L, Head K, Fielder AR (2008) UK retinopathy of prematurity guideline. Early Hum Dev 84(2):71\u201374. https:\/\/doi.org\/10.1016\/j.earlhumdev.2007.12.004","journal-title":"Early Hum Dev"},{"key":"7260_CR7","doi-asserted-by":"publisher","unstructured":"Mataftsi A, Moutzouri S, Charonis A, Seliniotaki AK, Haidich AB, Ziakas N (2025) The incidence of treatment-requiring retinopathy of prematurity in Greece: A multicenter prospective cohort study. Ophthalmic Epidemiol 1\u20137. https:\/\/doi.org\/10.1080\/09286586.2025.2463069","DOI":"10.1080\/09286586.2025.2463069"},{"key":"7260_CR8","doi-asserted-by":"publisher","unstructured":"Moutzouri S, Chaaya C, Altamirano F, Pandiri S, Hoyek S, Abousifein M et al (2025) Validation of the TWO-ROP algorithm in a tertiary care centre in Greece. Acta Ophthalmol 3. https:\/\/doi.org\/10.1111\/aos.70053","DOI":"10.1111\/aos.70053"},{"issue":"10","key":"7260_CR9","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.ophtha.2021.05.031","volume":"128","author":"MF Chiang","year":"2021","unstructured":"Chiang MF, Quinn GE, Fielder AR, Ostmo SR, Paul Chan RV, Berrocal A et al (2021) International Classification of Retinopathy of Prematurity, Third Edition. Ophthalmology 128(10):e51\u201368. https:\/\/doi.org\/10.1016\/j.ophtha.2021.05.031","journal-title":"Ophthalmology"},{"issue":"7","key":"7260_CR10","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/archopht.123.7.991","volume":"123","author":"The International Classification of Retinopathy of Prematurity Revisited","year":"2005","unstructured":"The International Classification of Retinopathy of Prematurity Revisited (2005) Arch Ophthalmol 123(7):991. https:\/\/doi.org\/10.1001\/archopht.123.7.991","journal-title":"Arch Ophthalmol"},{"issue":"13","key":"7260_CR11","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1001\/jama.1983.03330370053031","volume":"249","author":"JA Hanley","year":"1983","unstructured":"Hanley JA, Lippman-Hand A (1983) If nothing goes wrong, is everything all right? Interpreting zero numerators. JAMA 249(13):1743\u20131745","journal-title":"JAMA"},{"issue":"4","key":"7260_CR12","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.pcl.2020.04.012","volume":"67","author":"A Barrero-Castillero","year":"2020","unstructured":"Barrero-Castillero A, Corwin BK, VanderVeen DK, Wang JC (2020) Workforce Shortage for Retinopathy of Prematurity Care and Emerging Role of Telehealth and Artificial Intelligence. Pediatr Clin North Am 67(4):725\u2013733. https:\/\/doi.org\/10.1016\/j.pcl.2020.04.012","journal-title":"Pediatr Clin North Am"},{"issue":"1","key":"7260_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/IIO.0000000000000552","volume":"65","author":"C Chaaya","year":"2025","unstructured":"Chaaya C, Hoyek S, Patel NA (2025) Update on Management of Retinopathy of Prematurity: A Review. Int Ophthalmol Clin 65(1):81\u201390. https:\/\/doi.org\/10.1097\/IIO.0000000000000552","journal-title":"Int Ophthalmol Clin"},{"issue":"5","key":"7260_CR14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1001\/jamaophthalmol","volume":"141","author":"A Bhatnagar","year":"2023","unstructured":"Bhatnagar A, Skrehot HC, Bhatt A, Herce H, Weng CY (2023) Epidemiology of Retinopathy of Prematurity in the US From 2003 to 2019. JAMA Ophthalmol 141(5):479\u2013485. https:\/\/doi.org\/10.1001\/jamaophthalmol","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"7260_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.oret.2023.10.003","volume":"8","author":"SD Scarboro","year":"2024","unstructured":"Scarboro SD, Harper CA, Karsaliya G, Ghoraba H, Moshfeghi DM, Al-Khersan H et al (2024) The Incidence and Timing of Treatment-Requiring Retinopathy of Prematurity in Nanopremature and Micropremature Infants in the United States: A National Multicenter Retrospective Cohort Study. Ophthalmol Retina 8(3):279\u2013287. https:\/\/doi.org\/10.1016\/j.oret.2023.10.003","journal-title":"Ophthalmol Retina"},{"issue":"25","key":"7260_CR16","doi-asserted-by":"publisher","first-page":"00252","DOI":"10.1016\/j.oret.2025.05.026","volume":"S2468\u20136530","author":"M Yuan","year":"2025","unstructured":"Yuan M, Altamirano F, Hu D, Hoyek S, Chaaya C, Abidi M et al (2025) Timing of Retinopathy of Prematurity Diagnosis and Treatment in Micro-Premature and Nano-Premature Infants during Inpatient Screening. Ophthalmol Retina S2468\u20136530(25):00252\u201300250. https:\/\/doi.org\/10.1016\/j.oret.2025.05.026","journal-title":"Ophthalmol Retina"},{"key":"7260_CR17","doi-asserted-by":"publisher","unstructured":"Yuan M, Chaaya C, Altamirano F, Hu D, Hoyek S, Abidi M et al (2025) Retinopathy of prematurity in the extremely premature: Disease burden, treatment approaches, and visual outcomes in micro- and nano-premature infants. Am J Ophthalmol S0002939425004076. https:\/\/doi.org\/10.1016\/j.ajo.2025.08.004","DOI":"10.1016\/j.ajo.2025.08.004"},{"issue":"1","key":"7260_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.oret.2024.07.010","volume":"9","author":"NA Patel","year":"2025","unstructured":"Patel NA, Altamirano F, Hoyek S, De Bruyn H, Fulton A, Gise R et al (2025) Validation of the TWO-ROP Algorithm at a Multi-Neonatal Intensive Care Unit Tertiary Referral Center. Ophthalmol Retina 9(1):63\u201368. https:\/\/doi.org\/10.1016\/j.oret.2024.07.010","journal-title":"Ophthalmol Retina"},{"issue":"9","key":"7260_CR19","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1001\/jamaophthalmol.2018.2753","volume":"136","author":"G Binenbaum","year":"2018","unstructured":"Binenbaum G, Bell EF, Donohue P, Quinn G, Shaffer J, Tomlinson LA et al (2018) Development of Modified Screening Criteria for Retinopathy of Prematurity: Primary Results From the Postnatal Growth and Retinopathy of Prematurity Study. JAMA Ophthalmol 136(9):1034. https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.2753","journal-title":"JAMA Ophthalmol"},{"key":"7260_CR20","doi-asserted-by":"publisher","unstructured":"Hellstr\u00f6m A, H\u00e5rd AL, Engstr\u00f6m E, Niklasson A, Andersson E, Smith L et al (2009) Early weight gain predicts retinopathy in preterm infants: New, simple, efficient approach to screening. Pediatrics 16. https:\/\/doi.org\/10.1542\/peds.2008-2697","DOI":"10.1542\/peds.2008-2697"},{"issue":"1","key":"7260_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1001\/jamaophthalmol.2019.4502","volume":"138","author":"A Pivodic","year":"2020","unstructured":"Pivodic A, H\u00e5rd AL, L\u00f6fqvist C, Smith LEH, Wu C, Br\u00fcnder MC et al (2020) Individual Risk Prediction for Sight-Threatening Retinopathy of Prematurity Using Birth Characteristics. JAMA Ophthalmol 138(1):21. https:\/\/doi.org\/10.1001\/jamaophthalmol.2019.4502","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"7260_CR22","doi-asserted-by":"publisher","first-page":"e20183061","DOI":"10.1542\/peds.2018-3061","volume":"142","author":"WM Fierson","year":"2018","unstructured":"Fierson WM, American academy of pediatrics Section on Ophthalmology, American academy of ophthalmology, American association for pediatric ophthalmology and strabismus, American association of certified orthoptists (2018) Screening Examination of Premature Infants for Retinopathy of Prematurity. Pediatrics 142(6):e20183061. https:\/\/doi.org\/10.1542\/peds.2018-3061","journal-title":"Pediatrics"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07260-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-026-07260-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07260-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:53:25Z","timestamp":1789455205000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-026-07260-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["7260"],"URL":"https:\/\/doi.org\/10.1007\/s00417-026-07260-x","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Human ethics and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NAP is a consultant for Apellis, Alcon, Allergan, Atheneum, biogen, Dorc, Alimera, Eye Point, Genentech, Regenx Bio, Regeneron, Lifesciences, Guidepoint, and Gerson Lehrman Group, Inc.The following authors have no relevant financial disclosures: SM, CC, FA, SP, SH, AM","order":3,"name":"Ethics","label":"Financial disclosures","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}